United Therapeutics Converts to a Public Benefit Corporation

Downtown Silver Spring-based United Therapeutics Corporation yesterday announced that following shareholder approval, it has officially converted to a public benefit corporation (PBC), the first PBC conversion of a public biotech or pharmaceutical company. “We are inspired by our shareholders who recognize that caring for our patients, planet, employees, communities, and other stakeholders enhances our ability to generate strong shareholder returns,” Martine Rothblatt, Ph.D., Chairperson and Chief Executive Officer of United Therapeutics, said in a statement.